Role of maintenance chemotherapy in acute promyelocytic leukemia.

  title={Role of maintenance chemotherapy in acute promyelocytic leukemia.},
  author={Hagop M Kantarjian and Michael J Keating and Ron Walters and Terry L. Smith and Kenneth B. McCredie and Emil J. Freireich},
  volume={59 7},
The effect of maintenance chemotherapy on remission duration was analyzed in 39 of 70 patients (56%) with acute promyelocytic leukemia (APL) who achieved complete remission on induction chemotherapy. Overall, the median remission duration was 26 months, with a 3-year remission rate of 42%. The 3-year remission rate was significantly higher in patients who received 6-mercaptopurine and methotrexate (POMP) during maintenance, compared with those who did not (56% versus 30%; P less than 0.01), and… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 14 extracted citations

Acute myeloid leukemia and acute promyelocytic leukemia.

Hematology. American Society of Hematology. Education Program • 2003